Aspire Biopharma Holdings Inc吧
排序：
评论时间
  • 评论时间
  • 发帖时间
阅读评论标题 作者 最后更新
97 0 还是美股好玩 跟随多头趋势力量 08-18 22:41
34 0 公告 Quarterly report [Sections 13 or 15(d)] Aspire Biopharma资讯 08-14 05:10
28 0 公告 [Amend] Quarterly report [Sections 13 or 15(d)] Aspire Biopharma资讯 08-14 05:07
29 0 公告 Current report, items 5.02 and 9.01 Aspire Biopharma资讯 07-31 05:35
134 0 美股的生物科技基本都是低价股轮流大涨！ 股友6Q07079Z62 07-10 00:29
32 0 公告 Current report, items 8.01 and 9.01 Aspire Biopharma资讯 06-19 05:32
53 0 公告 [Amend] Statement of changes in beneficial ownersh Aspire Biopharma资讯 06-11 05:28
31 0 公告 Current report, items 5.02, 7.01, and 9.01 Aspire Biopharma资讯 06-10 20:33
29 0 公告 Statement of changes in beneficial ownership of se Aspire Biopharma资讯 06-07 06:14
41 0 公告 Notice of Effectiveness Aspire Biopharma资讯 05-30 18:05
70 0 是做什么的，怎么涨这么多 国服亏损小王子 05-29 13:26
170 0 公告 [Cover]Correspondence Aspire Biopharma资讯 05-28 00:00
33 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 05-20 08:33
159 0 公告 [Cover]SEC-generated letter Aspire Biopharma资讯 05-20 00:00
38 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 05-16 00:18
35 0 公告 Quarterly report [Sections 13 or 15(d)] Aspire Biopharma资讯 05-15 04:49
33 0 公告 General form for registration of securities under Aspire Biopharma资讯 05-14 05:24
39 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 05-08 05:18
34 0 公告 Current report, items 1.01 and 9.01 Aspire Biopharma资讯 05-01 05:03
35 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 04-24 07:51
27 0 公告 Notice of Effectiveness Aspire Biopharma资讯 04-22 18:04
40 0 公告 Current report, items 3.01 and 9.01 Aspire Biopharma资讯 04-19 04:36
31 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 04-18 04:25
90 0 公告 [Cover]Correspondence Aspire Biopharma资讯 04-18 00:00
95 0 公告 [Cover]SEC-generated letter Aspire Biopharma资讯 04-16 00:00
40 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 04-12 05:05
31 0 公告 General form for registration of securities under Aspire Biopharma资讯 04-09 18:27
22 0 公告 Annual report [Section 13 and 15(d), not S-K Item Aspire Biopharma资讯 04-07 19:32
34 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 04-05 05:31
38 0 公告 Notification of inability to timely file Form 10-K Aspire Biopharma资讯 04-01 05:33
28 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 03-29 05:32
30 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 03-21 10:01
34 0 公告 [Amend] Statement of Beneficial Ownership by Certa Aspire Biopharma资讯 03-13 04:09
127 0 why？it'sterrible! 给我一片绿洲 03-05 22:39
28 0 公告 Statement of Beneficial Ownership by Certain Inves Aspire Biopharma资讯 02-27 10:23
170 0 那逼 刺客屠龙 02-22 11:02
30 0 公告 Current report, items 1.01, 2.01, 2.03, 3.02, 3.03 Aspire Biopharma资讯 02-22 06:25
42 0 公告 Current report, items 1.01, 2.03, 3.02, 7.01, and Aspire Biopharma资讯 02-21 05:48
50 0 公告 Notification filed by national security exchange t Aspire Biopharma资讯 02-20 05:01
80 0 公告 Current report, items 5.07, 8.01, and 9.01 Aspire Biopharma资讯 02-11 05:23
216 0 公告 Notice of Effectiveness Aspire Biopharma资讯 01-15 19:08
224 0 公告 Prospectus [Rule 424(b)(3)] Aspire Biopharma资讯 01-15 05:38
551 0 公告 [Cover]Correspondence Aspire Biopharma资讯 01-13 00:00
554 0 公告 [Cover]Correspondence Aspire Biopharma资讯 01-10 00:00
237 0 公告 [Amend] Registration of securities, business combi Aspire Biopharma资讯 01-09 06:17
280 0 公告 Prospectuses and communications, business combinat Aspire Biopharma资讯 12-27 05:12
272 0 公告 Current report, items 1.01, 3.02, and 9.01 Aspire Biopharma资讯 12-27 05:11
288 0 公告 [Amend] Registration of securities, business combi Aspire Biopharma资讯 12-24 06:36
554 0 公告 [Cover]Correspondence Aspire Biopharma资讯 12-23 00:00
543 0 公告 [Cover]SEC-generated letter Aspire Biopharma资讯 12-19 00:00
237 0 公告 [Amend] Registration of securities, business combi Aspire Biopharma资讯 12-11 06:30
560 0 公告 [Cover]Correspondence Aspire Biopharma资讯 12-10 00:00
549 0 公告 [Cover]SEC-generated letter Aspire Biopharma资讯 12-02 00:00
92 0 公告 [Amend] Registration of securities, business combi Aspire Biopharma资讯 11-16 05:16
87 0 公告 Quarterly report [Sections 13 or 15(d)] Aspire Biopharma资讯 11-15 09:11
554 0 公告 [Cover]Correspondence Aspire Biopharma资讯 11-15 00:00
438 0 公告 [Cover]SEC-generated letter Aspire Biopharma资讯 11-08 00:00
552 0 公告 [Cover]SEC-generated letter Aspire Biopharma资讯 11-07 00:00
88 0 公告 [Amend] Quarterly report [Sections 13 or 15(d)] Aspire Biopharma资讯 10-25 06:37
90 0 公告 [Amend] Quarterly report [Sections 13 or 15(d)] Aspire Biopharma资讯 10-25 06:35
82 0 公告 [Amend] Registration of securities, business combi Aspire Biopharma资讯 10-24 19:49
419 0 公告 [Cover]Correspondence Aspire Biopharma资讯 10-24 00:00
546 0 公告 [Cover]Correspondence Aspire Biopharma资讯 10-23 00:00
433 0 公告 [Cover]SEC-generated letter Aspire Biopharma资讯 10-15 00:00
157 0 公告 Prospectuses and communications, business combinat Aspire Biopharma资讯 10-11 04:27
169 0 公告 Current report, items 1.01 and 9.01 Aspire Biopharma资讯 10-11 04:17
554 0 公告 [Cover]SEC-generated letter Aspire Biopharma资讯 10-08 00:00
154 0 公告 Prospectuses and communications, business combinat Aspire Biopharma资讯 10-05 05:41
150 0 公告 Current report, items 1.01 and 9.01 Aspire Biopharma资讯 10-05 05:36
133 0 公告 Registration of securities, business combinations Aspire Biopharma资讯 09-07 05:19
121 0 公告 Prospectuses and communications, business combinat Aspire Biopharma资讯 09-07 04:12
128 0 公告 Current report, items 1.01 and 9.01 Aspire Biopharma资讯 09-07 04:12
106 0 公告 Current report, items 8.01 and 9.01 Aspire Biopharma资讯 09-03 20:06
98 0 公告 Current report, items 1.01 and 9.01 Aspire Biopharma资讯 08-31 05:33
96 0 公告 Prospectuses and communications, business combinat Aspire Biopharma资讯 08-31 05:30
发表新主题
悬赏提问
帖子不见了！怎么办？   
   请登录 登录 | 5秒注册 作者： 退出 
温馨提示： 1.根据《证券法》规定，禁止编造、传播虚假信息或者误导性信息，扰乱证券市场；2.用户在本社区发表的所有资料、言论等仅代表个人观点，与本网站立场无关，不对您构成任何投资建议。用户应基于自己的独立判断，自行决定证券投资并承担相应风险。《东方财富社区管理规定》
东方财富

扫一扫下载APP
东方财富产品
证券交易
关注东方财富
天天基金

扫一扫下载APP
基金交易
关注天天基金
东方财富期货

扫一扫下载APP
期货交易
信息网络传播视听节目许可证：0908328号 经营证券期货业务许可证编号：913101046312860336 违法和不良信息举报:021-34289898 举报邮箱：jubao@eastmoney.com
沪ICP证:沪B2-20070217 网站备案号:沪ICP备05006054号-11 沪公网安备 31010402000120号 版权所有:东方财富网 意见与建议:021-54509966/952500
关于我们 广告服务 联系我们 诚聘英才 免责声明 法律声明 隐私保护 征稿启事 放心搜 友情链接